Skip to main content
HairCited

マイクロニードリング 円形脱毛症

A

合計1,908名の参加者を対象とした32件の研究(メタアナリシス1件、RCT 9件を含む)に基づく。32件中25件の研究で肯定的な効果が示されている。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dmicroneedling\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

結論

Microneedling has strong evidence for supporting hair regrowth in alopecia areata, especially when combined with topical medications, and is backed by multiple randomized controlled trials.

  • 25 out of 32 studies show positive effects, with 9 RCTs providing robust evidence
  • Works by creating micro-injuries that stimulate healing responses and improve drug absorption
  • Most effective when combined with topical agents like corticosteroids or vitamin D3
  • Both professional clinical procedures and at-home derma rollers have been studied

Key Study Findings

scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) vs: Placebo 効果: None None
retrospective cohort n=7 Open-label
Combination Therapy With CGF and Microneedling-Assisted Compound Betamethasone for Resistant Alopecia Areata: A Pilot Study.
Dose: Concentrated growth factor (CGF) combined with microneedling-assisted compound betamethasone; multip vs: Placebo 効果: 85.7% achieved complete recovery; 14.3% achieved >50% regrowth; significant SALT score improvement None
randomized controlled trial n=24 18 weeks Open-label
A Comparative Clinical and Trichoscopic Study Between Fractional Radiofrequency Microneedling Versus Intralesional Steroids in Treatment …
Dose: Fractional radiofrequency microneedling (FRM), 6 sessions with 3-week intervals vs: Placebo 効果: Comparable efficacy between FRM and ILCS; nonsignificant differences in trichoscopic scores, PGA, an None
review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera vs: Placebo 効果: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None
animal study 2 weeks
Investigating the potential mechanism of microneedling in alopecia areata mice based on 16S rRNA sequencing …
Dose: Halometasone topical applied every 2 days for 2 weeks after hand-held dermal microneedling treatment vs: Placebo 効果: Microneedling enhanced hair growth; restored gut microbiome diversity; reduced acetic acid and propa None

Key Statistics

34

研究数

1908

参加者数

Positive

A

グレード

Referenced Papers

Skin appendage disorders 2024 5 件の引用
The Journal of … 2024 2 件の引用
Dermatology and therapy 2022 43 件の引用
Journal of the … 2020 10 件の引用
Proceedings (Baylor University. … 2020 8 件の引用
Journal of the … 2018 114 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

hairloss:
1.5 mm depth, weekly sessions

上限量: Not applicable

研究で検討された用量

用量 期間 効果 N
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
Concentrated growth factor (CGF) combined with microneedling-assisted compound betamethasone; multip -- Positive 7
None -- Mixed --
Fractional radiofrequency microneedling (FRM), 6 sessions with 3-week intervals 18 weeks Neutral 24
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
Halometasone topical applied every 2 days for 2 weeks after hand-held dermal microneedling treatment 2 weeks Positive --
Microinfusion of medications into the skin (MMP) using tattoo devices; various drugs (minoxidil, ste -- Positive --
Melatonin 3 mg/kg; PBM diode laser 660nm, 100mW, 3 J/point, 2 sessions/week 12 weeks Mixed 60

推奨摂取タイミング: Weekly sessions; avoid minoxidil for 24 hours post-treatment

Safety & Side Effects

報告されている副作用

  • Scalp redness and inflammation (24-72 hours)
  • Mild bleeding at treatment site
  • Scalp tenderness and soreness
  • Rare: infection if proper sterilization not maintained

既知の相互作用

  • Topical minoxidil (enhanced absorption; wait 24 hours after microneedling to apply)
  • Blood thinners (may increase bleeding during procedure)
  • Topical retinoids (discontinue 3-5 days before treatment)

耐容上限摂取量: Not applicable

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does マイクロニードリング help with 円形脱毛症?
Based on 34 studies with 1,908 participants, there is strong evidence from multiple clinical trials that マイクロニードリング may support 円形脱毛症 management. Our evidence grade is A (Strong Evidence).
How much マイクロニードリング should I take for 円形脱毛症?
Studies have used various dosages. A commonly studied range is 1.5 mm depth, weekly sessions. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of マイクロニードリング?
Reported side effects may include Scalp redness and inflammation (24-72 hours), Mild bleeding at treatment site, Scalp tenderness and soreness, Rare: infection if proper sterilization not maintained. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for マイクロニードリング and 円形脱毛症?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 34 peer-reviewed studies with 1,908 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。